Harte Hanks (HHS) Fundamental Analysis: Revenue, Earnings & Valuation

0.48 / 10

Underperform

Fundamentals are underperforming (score 0.48). Revenue‑MV ranks high (group 4) but PB‑ROE and Asset‑MV are negative, dragging the rating. Net profit/Total profit and Net profit‑to‑Revenue are weak. Overall, financial health is poor, suggesting caution.

Analysis Checks(5/10)

Revenue-MV

Value1.95

Score3/3

Weight-65.04%

1M Return2.01%

Net assets per share (growth rate compared to beginning of year %)

Value-6.09

Score2/3

Weight-32.32%

1M Return1.08%

Operating cycle

Value67.11

Score1/3

Weight-3.39%

1M Return0.11%

Profit-MV

Value0.66

Score2/3

Weight13.31%

1M Return-0.46%

Net income-Revenue

Value-1.14

Score2/3

Weight13.69%

1M Return-0.45%

PB-ROE

Value-0.82

Score1/3

Weight48.97%

1M Return-1.63%

Asset-MV

Value-0.55

Score0/3

Weight86.66%

1M Return-3.27%

Inventory turnover days

Value213.26

Score3/3

Weight-7.27%

1M Return0.24%

Cash-MV

Value-0.60

Score1/3

Weight57.98%

1M Return-2.37%

Net profit / Total profit (%)

Value80.46

Score1/3

Weight-12.60%

1M Return0.40%

Is HHS fundamentally strong?

HHS scores 0.48/10 on fundamentals and holds a Premium valuation at present. Backed by its -3.84% ROE, -0.51% net margin, -22.86 P/E ratio, 0.90 P/B ratio, and 97.35% earnings growth, these metrics solidify its Underperform investment rating.